Zhengye Biotechnology Holding Limited (NasdaqCM: ZYBT)
Health Care · Pharmaceuticals · CN
$1.83
+17.31% today · -80.1% 1Y
Zhengye Biotechnology Holding Limited (NasdaqCM: ZYBT) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $73.93M and employs 269 people.
Over the last twelve months the share price has lost 80.1%, trading between 0.62 and 13.08.
Tweenvest scores Zhengye Biotechnology Holding Limited across four factors: quality 62/100, value 63/100. Its strongest factor is value.
ZYBT price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $73.93M
- Revenue (TTM)
- $16.64M
- P/E
- —
- EPS
- -1.47
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $13.08
- 52-week low
- $0.62
- Avg volume (3M)
- —
- Shares outstanding
- 47.39M
- Employees
- 269
- Next earnings
- —
About Zhengye Biotechnology Holding Limited
Zhengye Biotechnology Holding Limited specializes in the creation, manufacturing, and commercialization of animal health immunizations. The company primarily supplies the Chinese agricultural sector with vaccines tailored for a broad spectrum of farm animals, including swine, bovines, goats, ovines, and poultry. Additionally, its product range encompasses inoculations for canines. Beyond its domestic reach, the firm also distributes its offerings to international markets, notably exporting to Vietnam, Pakistan, and Egypt. Established in 2004, this enterprise bases its principal operations in Jilin, China, and operates as a subsidiary entity of Securingium Holding Limited.
- ISIN
- KYG989MS1016
- Founded
- 2004
- Listed since
- Jan 7, 2025
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.10T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $658.24B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $385.99B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $371.62B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $303.81B | CHF128.34 | +1.25% |
| AstraZeneca PLCLSE: AZN | $263.84B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $212.51B | Dkr307.80 | +2.86% |
| Pfizer Inc.NYSE: PFE | $162.84B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.